Search by Drug Name or NDC
NDC 62135-0549-43 Lorazepam 2 mg/mL Details
Lorazepam 2 mg/mL
Lorazepam is a ORAL CONCENTRATE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chartwell RX, LLC. The primary component is LORAZEPAM.
MedlinePlus Drug Summary
Lorazepam is used to relieve anxiety. Lorazepam is also used to treat insomnia caused by anxiety or temporary situational stress. Lorazepam is in a class of medications called benzodiazepines. It works by slowing activity in the brain to allow for relaxation.
Related Packages: 62135-0549-43Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Lorazepam
Product Information
| NDC | 62135-0549 |
|---|---|
| Product ID | 62135-549_044c464b-af13-d50f-e063-6394a90ade25 |
| Associated GPIs | |
| GCN Sequence Number | 016363 |
| GCN Sequence Number Description | lorazepam ORAL CONC 2 MG/ML ORAL |
| HIC3 | H20 |
| HIC3 Description | ANTI-ANXIETY - BENZODIAZEPINES |
| GCN | 19601 |
| HICL Sequence Number | 004846 |
| HICL Sequence Number Description | LORAZEPAM |
| Brand/Generic | Generic |
| Proprietary Name | Lorazepam |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Lorazepam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CONCENTRATE |
| Route | ORAL |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | mg/mL |
| Substance Name | LORAZEPAM |
| Labeler Name | Chartwell RX, LLC |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA079244 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 62135-0549-43 (62135054943)
| NDC Package Code | 62135-549-43 |
|---|---|
| Billing NDC | 62135054943 |
| Package | 30 mL in 1 BOTTLE (62135-549-43) |
| Marketing Start Date | 2023-04-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |